author-photo

Richard Haynes

Medical Research Council
Clinical Trial Service Unit

28

Papers

1235

Citations

Citation Trend

Filter By

Papers (28) Sort By

Journal Conference Others

taleNeprilysin and Neprilysin inhibition in chronic kidney disease.

2020 Current Opinion in Nephrology and Hypertension
- Parminder K. Judge
- Richard Haynes
Show All
- Source
- Cite
- Save
Citations (2)
Cost-effectiveness of lowering LDL cholesterol with statins and ezetimibe in chronic kidney disease

2019 Kidney International
Show All
- Source
- Cite
- Save
Citations (0)
Chronic kidney disease, heart failure and neprilysin inhibition

2019 Nephrology Dialysis Transplantation
Show All
- Source
- Cite
- Save
Citations (16)
Assessement of Vascular Event Prevention and Cognitive Function Among Older Adults With Preexisting Vascular Disease or Diabetes: A Secondary Analysis of 3 Randomized Clinical Trials.

2019
Show All
- Source
- Cite
- Save
Citations (5)
In high-risk T2DM, canagliflozin reduced CV events regardless of baseline renal function.

2019 Annals of Internal Medicine
Show All
- Source
- Cite
- Save
Citations (0)
Detecting cognitive effects of vascular event prevention in randomized trials

2019 JAMA
Show All
- Source
- Cite
- Save
Citations (0)
Effects of Aspirin for Primary Prevention in Persons with Diabetes Mellitus.

2018 The New England Journal of Medicine
Show All
- Source
- Cite
- Save
Citations (497)
ELECTIVE CONVERSION TO SIROLIMUS VS. CONTINUED TACROLIMUS IN KIDNEY TRANSPLANTATION (THE 3C STUDY): RESULTS OF A RANDOMIZED TRIAL

2018 American Journal of Transplantation
Show All
- Source
- Cite
- Save
Citations (0)
PCSK9 inhibition: ready for prime time in CKD?

2018 Kidney International
- Marion Mafham
- Richard Haynes
Show All
- Source
- Cite
- Save
Citations (6)
Effects of n-3 Fatty Acid Supplements in Diabetes Mellitus.

2018 The New England Journal of Medicine
Show All
- Source
- Cite
- Save
Citations (304)